SLC2A5 and posterior cortical atrophy: Observed in a single European patient, a 3,836 base DUP directly impacts exon 4 of SLC2A5 (Supplementary Fig. 11), which downregulated in PCa (P < 0.001, GENT2 T-test) and has been identified an oncogenic behaviour (Supplementary Table 7), therefore allocated PP-SV status.